Eicosapentaenoic Acid-Enriched Phosphatidylcholine Attenuated Hepatic Steatosis Through Regulation of Cholesterol Metabolism in Rats with Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Eicosapentaenoic Acid-Enriched Phosphatidylcholine Attenuated Hepatic Steatosis Through Regulation of Cholesterol Metabolism in Rats with Nonalcoholic Fatty Liver Disease

Published:2016-12-24 Issue:2 Volume:52 Page:119-127
ISSN:0024-4201
Container-title:Lipids
language:en
Short-container-title:Lipids

Author:

Liu Yanjun¹,Shi Di¹,Tian Yingying¹,Liu Yuntao²,Zhan Qiping¹,Xu Jie¹,Wang Jingfeng¹,Xue Changhu¹

Affiliation:

1. ; College of Food Science and Engineering; Ocean University of China; 5 Yushan Road Qingdao Shandong Province 266003 China

2. Shandong Oriental Ocean Sci-tech Co., Ltd.; Yantai Shandong Province 264003 China

Funder

National Natural Science Foundation of China

Science and Technology Development Plan of Shandong Province

National Science & Technology Pillar Program

National Science & Technology Pillar Program during the 12th Five-year Plan Period

Publisher

Wiley

Subject

Cell Biology,Organic Chemistry,Biochemistry

Link

http://link.springer.com/article/10.1007/s11745-016-4222-1/fulltext.html

Reference43 articles.

1. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease;Nomura;J Nutr Biochem,2012

2. Nonalcoholic fatty liver disease;Krawczyk;Best Pract Res Clin Gastroenterol,2010

3. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis;Musso;Prog Lipid Res,2013

4. Nonalcoholic fatty liver disease and serum lipoproteins: the multi-ethnic study of atherosclerosis;DeFilippis;Atherosclerosis,2013

5. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease;Targher;N Engl J Med,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural compounds against nonalcoholic fatty liver disease: A review on the involvement of the LKB1/AMPK signaling pathway;Phytotherapy Research;2023-09-25

2. Approbation of a Model of Fat Liver Disease Induced by Orotic Acid;Drug development & registration;2022-11-27

3. Sea cucumber-derived compounds for treatment of dyslipidemia: A review;Frontiers in Pharmacology;2022-09-14

4. Approaches for modifying cellular cholesterol levels and their application to mechanistic studies: Examples from the ion channel field;Cholesterol;2022

5. Omega‐3 phospholipids and obesity‐associated NAFLD: Potential mechanisms and therapeutic perspectives;European Journal of Clinical Investigation;2021-08-02